KUALA LUMPUR: The administration of Pfizer BioNTech Covid-19 vaccine to children under the age of 12 will begin in 2022, according to the Health Ministry (MOH).
MOH said that currently, only the Pfizer-BioNTech Covid-19 vaccine is available for use in children below 12 and it is awaiting regulatory approval from the European Union and the United States.
Already a subscriber? Log in.
Subscribe or renew your subscriptions to win prizes worth up to RM68,000!
Cancel anytime. No ads. Auto-renewal. Unlimited access to the web and app. Personalised features. Members rewards.
Follow us on our official WhatsApp channel for breaking news alerts and key updates!
